Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Sonia D'Inzeo"'
Autor:
Arianna Nicolussi, Francesca Belardinilli, Valentina Silvestri, Yasaman Mahdavian, Virginia Valentini, Sonia D’Inzeo, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Stefano Di Giulio, Francesca Fabretti, Beatrice Fratini, Angela Gradilone, Laura Ottini, Giuseppe Giannini, Anna Coppa, Carlo Capalbo
Publikováno v:
PeerJ, Vol 7, p e7972 (2019)
Background Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires screening for single nucleotide variants, small insertions/deletions and large genomic rearrangements (LGRs). These studies have long been
Externí odkaz:
https://doaj.org/article/85e327b29acf4025bee0ed5b00f74e12
Autor:
Arianna Nicolussi, Francesca Belardinilli, Yasaman Mahdavian, Valeria Colicchia, Sonia D’Inzeo, Marialaura Petroni, Massimo Zani, Sergio Ferraro, Virginia Valentini, Laura Ottini, Giuseppe Giannini, Carlo Capalbo, Anna Coppa
Publikováno v:
PeerJ, Vol 7, p e6661 (2019)
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://doaj.org/article/af709bd668db45ada5e1a66a6ebf63d9
Autor:
Gabriella Mincione, Maria Carmela Di Marcantonio, Chiara Tarantelli, Sonia D'Inzeo, Arianna Nicolussi, Francesco Nardi, Caterina Francesca Donini, Anna Coppa
Publikováno v:
Journal of Thyroid Research, Vol 2011 (2011)
Normal epithelial thyroid cells in culture are inhibited by TGF-𝛽1. Instead, transformed thyroid cell lines are frequently resistant to its growth inhibitory effect. Loss of TGF-𝛽 responsiveness could be due to a reduced expression of TGF-𝛽
Externí odkaz:
https://doaj.org/article/d1f054c327fa45e996f48f65ae9a0d48
Autor:
Stefano Di Giulio, Francesca Belardinilli, Virginia Valentini, Carlo Capalbo, Sonia D'Inzeo, Sergio Ferraro, Arianna Nicolussi, Massimo Zani, Giuseppe Giannini, Francesca Fabretti, Angela Gradilone, Yasaman Mahdavian, Beatrice Fratini, Marialaura Petroni, Anna Coppa, Valentina Silvestri, Laura Ottini
Publikováno v:
PeerJ
PeerJ, Vol 7, p e7972 (2019)
PeerJ, Vol 7, p e7972 (2019)
Background Genetic testing for BRCA1/2 germline mutations in hereditary breast/ovarian cancer patients requires screening for single nucleotide variants, small insertions/deletions and large genomic rearrangements (LGRs). These studies have long been
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1550b5ae03cdc0f09ec7289649eb137a
http://europepmc.org/articles/PMC6859874
http://europepmc.org/articles/PMC6859874
Autor:
Yasaman Mahdavian, Francesca Belardinilli, Massimo Zani, Giuseppe Giannini, Anna Coppa, Sergio Ferraro, Virginia Valentini, Carlo Capalbo, Valeria Colicchia, Sonia D'Inzeo, Marialaura Petroni, Laura Ottini, Arianna Nicolussi
Publikováno v:
PeerJ, Vol 7, p e6661 (2019)
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a027fc8a4f14abb638ee412d31015024
http://hdl.handle.net/11573/1266940
http://hdl.handle.net/11573/1266940
Autor:
Arianna, Nicolussi, Francesca, Belardinilli, Yasaman, Mahdavian, Valeria, Colicchia, Sonia, D'Inzeo, Marialaura, Petroni, Massimo, Zani, Sergio, Ferraro, Virginia, Valentini, Laura, Ottini, Giuseppe, Giannini, Carlo, Capalbo, Anna, Coppa
Publikováno v:
PeerJ
Background Conventional methods used to identify BRCA1 and BRCA2 germline mutations in hereditary cancers, such as Sanger sequencing/multiplex ligation-dependent probe amplification (MLPA), are time-consuming and expensive, due to the large size of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d6448a180448bfdd6234c6d6adb5e99c
https://pubmed.ncbi.nlm.nih.gov/31065452
https://pubmed.ncbi.nlm.nih.gov/31065452
Autor:
Marialaura Petroni, Amelia Buffone, Valeria Colicchia, Arianna Nicolussi, Laura Ottini, Isabella Screpanti, Sonia D'Inzeo, Massimo Zani, Anna Coppa, Giuseppe Giannini, Francesca Belardinilli, Carlo Capalbo, Sergio Ferraro, Armando Bartolazzi, Christian Rinaldi
Publikováno v:
Cancer Medicine
The introduction of multigene panel testing for hereditary breast/ovarian cancer screening has greatly improved efficiency, speed, and costs. However, its clinical utility is still debated, mostly due to the lack of conclusive evidences on the impact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9573cad73b663b3c0d38cfa5440253a
https://pubmed.ncbi.nlm.nih.gov/29271107
https://pubmed.ncbi.nlm.nih.gov/29271107
Publikováno v:
Molecular and Clinical Oncology
Peroxiredoxins (PRDXs) are a ubiquitously expressed family of small (22-27 kDa) non-seleno peroxidases that catalyze the peroxide reduction of H2O2, organic hydroperoxides and peroxynitrite. They are highly involved in the control of various physiolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58a0a4b497382ac6ac53b589152ffbab
http://hdl.handle.net/11573/1014057
http://hdl.handle.net/11573/1014057
Autor:
Arianna Nicolussi, Massimo Zani, Sonia D'Inzeo, Francesco Nardi, Caterina Francesca Donini, Anna Coppa, Patrizia Mancini
Publikováno v:
Endocrine-Related Cancer. 19:39-55
Smad proteins are the key effectors of the transforming growth factor β (TGFβ) signaling pathway in mammalian cells. Smad4 plays an important role in human physiology, and its mutations were found with high frequency in wide range of human cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2caae6cf85621a3cdd9a216a77b75b1a
https://doi.org/10.1530/erc-11-0233
https://doi.org/10.1530/erc-11-0233
Autor:
Arianna Nicolussi, Valeria Colicchia, Marialaura Petroni, Anna Coppa, Francesca Belardinilli, Virginia Valentini, Sonia D'Inzeo, Carlo Capalbo, Giuseppe Giannini, Laura Ottini
Publikováno v:
ESMO Open. 3:A256
Introduction About 5%–10% of the hereditary breast and/or ovarian cancer (BC/BOC) is associated with an autosomal dominant genetic susceptibility due to highly penetrant mutations of the BRCA1/2 genes. In particular, BRCA1/2 gene mutations are foun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9621d45926a6ec7eaea08719e83155d
https://doi.org/10.1136/esmoopen-2018-eacr25.605
https://doi.org/10.1136/esmoopen-2018-eacr25.605